Private company

TREX WIND-DOWN, INC.

TREX WIND-DOWN, INC. is an American pharmaceutical preparations company based in Basking Ridge.1

Last updated Oct 21, 2026.

Overview

  • IndustryPharmaceutical Preparations1
  • HeadquartersWarren, New Jersey1
  • Incorporated inDE2
  • Business address3 Mountainview Road, Suite 100, Warren, Nj 070592
  • Filer categoryNon-accelerated filer, Smaller reporting company2
  • Legal formCorporation

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-23125.9%Operating margin3
-23299.0%Net margin3
-90.6%Revenue growth, 20223
-370.2%Return on equity3
-$15.9MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Research and development61¢$9.3M
  • Selling, general and admin39¢$6.0M
  • Income tax0¢$7.6K

Out of $83.2K in revenue.3 The company lost money this year.

Financial statements

Revenue45673$83.2K in 2022+30% since 2016
0$250.0K$500.0K$750.0K$1.0M2016: $64.0K$64.0K20162017: $100.0K$100.0K2017+56%2018: $73.0K$73.0K2018−27%2019: $57.0K$57.0K2019−22%2020: $453.8K$453.8K2020+696%2021: $886.5K$886.5K2021+95%2022: $83.2K$83.2K2022−91%
Gross profit4586-$26.0K in 2019−85% since 2016
-$600.0K-$400.0K-$200.0K02016: -$173.0K-$173.0K20162017: -$416.0K-$416.0K2017+140%2018: -$177.0K-$177.0K2018−57%2019: -$26.0K-$26.0K2019−85%
Operating income458673-$19.2M in 2022+27% since 2016
-$30.0M-$20.0M-$10.0M02016: -$15.2M-$15.2M20162017: -$18.4M-$18.4M2017+22%2018: -$16.9M-$16.9M2018−8%2019: -$16.5M-$16.5M2019−2%2020: -$20.2M-$20.2M2020+22%2021: -$10.7M-$10.7M2021−47%2022: -$19.2M-$19.2M2022+81%
Net income458673-$19.4M in 2022+24% since 2016
-$20.0M-$15.0M-$10.0M-$5.0M02016: -$15.6M-$15.6M20162017: -$18.4M-$18.4M2017+18%2018: -$16.6M-$16.6M2018−10%2019: -$17.3M-$17.3M2019+4%2020: -$15.1M-$15.1M2020−12%2021: -$10.6M-$10.6M2021−30%2022: -$19.4M-$19.4M2022+82%
Fiscal year2016201720182019202020212022
Revenue$64.0K4$100.0K5$73.0K5$57.0K6$453.8K7$886.5K3$83.2K3
Cost of revenue$237.0K4$516.0K5$250.0K8$83.0K6
Gross profit-$173.0K4-$416.0K5-$177.0K8-$26.0K6
Research and development$5.7M4$10.2M5$9.1M8$9.1M6$2.7M7$6.1M3$9.3M3
Selling, general and admin$4.1M7$5.4M3$6.0M3
Operating expenses$11.5M3$19.3M3
Operating income-$15.2M4-$18.4M5-$16.9M8-$16.5M6-$20.2M7-$10.7M3-$19.2M3
Interest$145.0K5
Income before tax-$10.7M3-$19.4M3
Income tax$4.0K4$2.0K5$2.0K8$2.0K6$37.8K7-$30.2K3$7.6K3
Net income-$15.6M4-$18.4M5-$16.6M8-$17.3M6-$15.1M7-$10.6M3-$19.4M3
Earnings per share-$0.977-$13.313-$9.193
Earnings per share (diluted)-$0.977-$13.313-$9.193
Shares (weighted, basic)808.8K shares32.1M shares3
Shares (weighted, diluted)808.8K shares32.1M shares3

Compare TREX WIND-DOWN, INC. with another company

Corporate structure

TREX WIND-DOWN, INC. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of TREX WIND-DOWN, INC.

  • TREX WIND-DOWN, INC. Warren, New Jersey

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What TREX WIND-DOWN, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net$19.4K3 Dec 31, 2022$16.4K3 Dec 31, 2021+18.3%
Operating-lease assets (leased space)$315.9K3 Dec 31, 2022$638.8K3 Dec 31, 2021−50.5%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$9.1M3 Dec 31, 2022$16.8M3 Dec 31, 2021−46.0%

Leadership

Who has led TREX WIND-DOWN, INC., and when. Pick a name to see everywhere that person has worked.

Board members and other officers (20)

Former names

  • Timber Pharmaceuticals, Inc.May 20, 2020 to Jan 26, 20242
  • BioPharmX CorpMar 4, 2014 to May 15, 20202
  • THOMPSON DESIGNS INCOct 27, 2010 to Feb 18, 20142

Timeline

  1. May 9, 20248-K Bankruptcy or receivership; Change to shareholders' rights; Change in control39
  2. May 9, 20248-K Bankruptcy or receivership; Change to shareholders' rights; Change in control40
  3. Apr 26, 20248-K Other events41
  4. Mar 26, 20248-K Other events42
  5. Feb 22, 20248-K Other events43
  6. Jan 26, 20248-K Bylaws or fiscal year changed; Other events44
  7. Jan 23, 20248-K Entered a material agreement; Bankruptcy or receivership; Completed an acquisition or sale45
  8. Dec 22, 20238-K Other events46
  9. Nov 28, 20238-K Listing notice or transfer; Regulation FD disclosure47
  10. Nov 17, 20238-K Shareholder vote48
  11. Nov 17, 20238-K Entered a material agreement; Ended a material agreement; Bankruptcy or receivership49
  12. Oct 30, 20238-K Entered a material agreement; New debt or obligation; Shareholder vote50
  13. May 20, 2020New chief executive John Koconis becomes CEO13
  14. Sep 13, 2018New chief executive David S. Tierney becomes CEO14
  15. Jan 30, 2014New chief executive James R. Pekarsky becomes CEO15
  16. Dec 13, 2013New chief executive Kade Thompson becomes CEO16

Calendar

When it reported results

  1. May 15, 2023Reported quarterly or annual results51
  2. Mar 31, 2023Reported quarterly or annual results52
  3. Nov 14, 2022Reported quarterly or annual results53
  4. Aug 12, 2022Reported quarterly or annual results54
  5. Jul 26, 2022Reported quarterly or annual results55
  6. May 12, 2022Reported quarterly or annual results56
  7. Apr 1, 2022Reported quarterly or annual results57
  8. Nov 15, 2021Reported quarterly or annual results58

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

140 filings to the SEC since October 2021: 2 annual reports, 6 quarterly reports, 57 major events, 22 insider forms, 4 large holders, 1 private raises, 48 other. The latest 20:

  1. May 10, 2024EFFECT EDGAR
  2. May 10, 2024EFFECT EDGAR
  3. May 10, 2024EFFECT EDGAR
  4. May 10, 2024EFFECT EDGAR
  5. May 10, 2024EFFECT EDGAR
  6. May 9, 202415-12G EDGAR
  7. May 9, 20248-K/A EDGAR
  8. May 9, 2024S-8 POS EDGAR
  9. May 9, 2024S-8 POS EDGAR
  10. May 9, 2024S-8 POS EDGAR
  11. May 9, 2024S-8 POS EDGAR
  12. May 9, 2024S-8 POS EDGAR
  13. May 9, 2024S-8 POS EDGAR
  14. May 9, 2024S-8 POS EDGAR
  15. May 9, 2024S-8 POS EDGAR
  16. May 9, 2024POS AM EDGAR
  17. May 9, 2024POS AM EDGAR
  18. May 9, 2024POS AM EDGAR
  19. May 9, 2024POS AM EDGAR
  20. May 9, 2024POS AM EDGAR

The 140 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

3 open-market trades by officers, directors and large owners since October 2021: 3 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Dec 15, 2021Koconis JohnCEO & ChairmanBuy20,000$0.38$7.6KForm 4
Nov 23, 2021Mendelsohn AlanEVP & CMOBuy10,000$0.47$4.7KForm 4
Nov 23, 2021Sitar Edward JDirectorBuy15,000$0.46$6.9KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. Oct 3, 2022Filed a private offering of equity63 Form D: 2 investors so far Form D

SEC filer profile

How TREX WIND-DOWN, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARTREX WIND-DOWN, INC.1
  • CIK0001504167
  • Employer ID (EIN)59-38431821
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address3 Mountainview Road, Suite 100, Warren, NJ 070591
  • Phone(917) 697-31301
  • Shares outstanding3,086,489 as of Aug 16, 202310
  • Public float$20.0M as of Jun 30, 20223
  • On EDGAR sinceOct 27, 20101
  • Filings625 in all: 8-K (171), 4 (121), 10-Q (38), 3 (31), CORRESP (27), EFFECT (19), SC 13G/A (17), UPLOAD (17)1
    All 56 form types

    S-1/A (14), 10-K (13), SC 13D/A (11), 424B5 (10), 425 (9), DEF 14A (9), DEFA14A (9), SC 13G (9), S-3 (8), S-8 (8), S-8 POS (8), D (7), SC 13D (7), 424B3 (5), POS AM (5), S-1 (5), NT 10-Q (4), PRE 14A (4), 424B4 (3), S-1MEF (3), 3/A (2), 8-K/A (2), NT 10-K (2), PRER14A (2), S-3/A (2), 10-K/A (1), 10-KT (1), 10-Q/A (1), 15-12G (1), 25-NSE (1), 4/A (1), 424B1 (1), 8-A12B (1), 8-A12G (1), ARS (1), CERTNAS (1), CT ORDER (1), D/A (1), DEF 14C (1), DEFM14A (1), DEFR14A (1), FWP (1), NO ACT (1), PRE 14C (1), PREM14A (1), S-4 (1), S-4/A (1), SC 14F1 (1)

  • Latest filingsAnnual report (10-K) Mar 31, 2023
    Quarterly report (10-Q) Aug 21, 2023
    Proxy statement (DEF 14A) May 1, 2023
    Latest 8-K (8-K) May 9, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
    SEC EDGAROther events
  42. 42
    SEC EDGAROther events
  43. 43
    SEC EDGAROther events
  44. 44
  45. 45
  46. 46
    SEC EDGAROther events
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63